Terra Innovatum Global N.V. (NKLR) Q2 2026 earnings summary

Executive summary

• Developing the SOLO micro-modular nuclear reactor, targeting commercial deployment by 2028, with a focus on affordable, decentralized, and clean energy solutions.

• Completed reactor design and initiated regulatory engagement with the U.S. NRC; no revenue generated as product remains under development.

• Business operates as a single segment, with all activities centered on R&D, regulatory, and supply chain planning for SOLO.

Financial highlights

• Net loss for Q2 2026 was $18,044K, compared to $1,145K in Q2 2025; net loss for the first half of 2026 was $25,150K, up from $2,593K in the prior year.

• Operating expenses for Q2 2026 were $6,079K, up 181% year-over-year, driven by higher consulting, insurance, and board compensation.

• Cash and cash equivalents as of June 30, 2026, were $91,055K; accumulated deficit reached $632,426K.

• Net cash used in operating activities for the first half of 2026 was $8,778K.

Outlook and guidance

• No revenue expected until at least 2028, pending completion of development, regulatory licensing, and commercialization.

• Anticipates continued increases in general and administrative expenses as a public company.

• Ongoing need for additional capital to fund operations and development; evaluating potential equity or debt financing.